ENDRA Life Sciences Inc (NASDAQ:NDRA) shares are trading lower by some 65% to $0.07 during Tuesday’s session. The company priced a public offering of 61,538,461 shares of common stock (or pre-funded ...

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound ...

The price trend for ENDRA Life Sciences Inc. (NDRA) has been bearish lately and the stock has lost 5.4% over the past week. However, the formation of a hammer chart pattern in its last trading session ...

) has been revised to $38.76 / share. This is a decrease of 17.39% from the prior estimate of $46.92 dated September 27, 2025. The price target is an average of many targets provided by analysts. The ...

Francois Michelon took the helm as ENDRA Life Sciences Inc’s (NASDAQ:NDRA) CEO and grew market cap to USD$15.75M recently. Recognizing whether CEO incentives are aligned with shareholders is a crucial ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Dividend history information is presently unavailable for this company. This could indicate that the company has never provided a dividend or that a dividend is pending. Nasdaq Data provided by Nasdaq ...